Life sciences firm Danaher has certainly not been an easy stock to own this year. A wave of startups going public on Wall Street would go a long ways toward changing that. '25 look ahead In addition to a continued rebound in bioprocessing, Danaher needs the Chinese economy to pick up steam, which should lead to an increase in orders from customers in the country. And a better IPO market is really good news for Danaher, as Jim explained during the December Monthly Meeting. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

---

Persons: Danaher, That's, we've, Jim Cramer's, Patience, Jim, China doesn't, we're, Jim Cramer, Stephen Hilger Organizations: Danaher, Management, Silicon Valley Bank, CNBC, Pall Corp, Sanofi Pasteur, Bloomberg, Getty Locations: China, bioprocessing, Silicon, Swiftwater , Pennsylvania